From this diverse set of DL methods modeling TF binding, gene expression, and chromatin conformation, neurodegenerative disease researchers can effectively model the genomic landscape of disease-implicated cell types and evaluate GWAS risk loci to nominate candidate causal variants for AD. This evidence concerns the gene TF and Alzheimer disease.